Lars Wallentin
Impact in
- Internal Medicine top 0.01%
- Venous Thromboembolism Diagnosis and Management
- Cardiology and Cardiovascular Medicine top 0.01%
- Atrial Fibrillation Management and Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Cardiac Arrhythmias and Treatments
- Cardiac electrophysiology and arrhythmias
Papers in
-
- Acute Myocardial Infarction Research 277
- Atrial Fibrillation Management and Outcomes 273
- Antiplatelet Therapy and Cardiovascular Diseases 222
- Cardiac Arrhythmias and Treatments 78
- Surgery 178
- Coronary Interventions and Diagnostics 85
- Lipoproteins and Cardiovascular Health 74
- Co-authors
- Stefan James (160 shared papers)Bertil Lindahl (78 shared papers)Salim Yusuf (82 shared papers)Stuart J. Connolly (86 shared papers)Michael D. Ezekowitz (77 shared papers)Paul Reilly (52 shared papers)Jonas Oldgren (87 shared papers)John W. Eikelboom (64 shared papers)
- Journals
- Journal of the American College of Cardiology (104 papers)European Heart Journal (95 papers)American Heart Journal (76 papers)Circulation (75 papers)Journal of the American Heart Association (26 papers)
- Partner nations
- SwedenUnited StatesCanada
In The Last Decade
Lars Wallentin
734 papers receiving 57.0k citations
Lars Wallentin's Hit Papers
Peers
Comparison fields: 5 of 186
- Internal Medicine 15.1k
- Cardiology and Cardiovascular Medicine 49.4k
- Radiology, Nuclear Medicine and Imaging 7.5k
- Surgery 14.3k
- Endocrinology, Diabetes and Metabolism 2.9k
Countries citing papers authored by Lars Wallentin
This map shows the geographic impact of Lars Wallentin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Wallentin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Wallentin more than expected).
Fields of papers citing papers by Lars Wallentin
This network shows the impact of papers produced by Lars Wallentin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Wallentin. The network helps show where Lars Wallentin may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Wallentin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 753 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dabigatran versus Warfarin in Patients with Atrial Fibrillation Hit paper breakdown → | 2009 | 7989 |
| 2 | Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes Hit paper breakdown → | 2009 | 4626 |
| 3 | Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery Disease Hit paper breakdown → | 2000 | 968 |
| 4 | Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden Hit paper breakdown → | 2007 | 871 |
| 5 | Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation Hit paper breakdown → | 2011 | 822 |
| 6 | Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial Hit paper breakdown → | 2010 | 728 |
| 7 | Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials Hit paper breakdown → | 2017 | 659 |
| 8 | Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials Hit paper breakdown → | 2002 | 650 |
| 9 | The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients Hit paper breakdown → | 2013 | 630 |
| 10 | Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial Hit paper breakdown → | 2010 | 582 |
| 11 | The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART) Hit paper breakdown → | 2010 | 570 |
| 12 | Routine vs Selective Invasive Strategies in Patients With Acute Coronary Syndromes Hit paper breakdown → | 2005 | 515 |
| 13 | 2000 | 471 | |
| 14 | 2001 | 462 | |
| 15 | 2003 | 445 | |
| 16 | 1996 | 439 | |
| 17 | Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study Hit paper breakdown → | 2010 | 436 |
| 18 | 1997 | 427 | |
| 19 | 2006 | 424 | |
| 20 | Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial Hit paper breakdown → | 2012 | 422 |
About Lars Wallentin
Lars Wallentin is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Radiology, Nuclear Medicine and Imaging, Internal Medicine and Endocrinology, Diabetes and Metabolism, having authored 753 papers that have together received 59.3k indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (277 papers), Atrial Fibrillation Management and Outcomes (273 papers), Antiplatelet Therapy and Cardiovascular Diseases (222 papers), Cardiac Imaging and Diagnostics (107 papers), Venous Thromboembolism Diagnosis and Management (104 papers), Coronary Interventions and Diagnostics (85 papers), Cardiac Arrhythmias and Treatments (78 papers) and Lipoproteins and Cardiovascular Health (74 papers). The work is most often cited by research in Internal Medicine (15.1k citations), Cardiology and Cardiovascular Medicine (49.4k citations), Radiology, Nuclear Medicine and Imaging (7.5k citations), Surgery (14.3k citations) and Endocrinology, Diabetes and Metabolism (2.9k citations). Lars Wallentin has collaborated with scholars based in Sweden, United States and Canada. Frequent co-authors include Stefan James, Bertil Lindahl, Salim Yusuf, Stuart J. Connolly, Michael D. Ezekowitz, Paul Reilly, Jonas Oldgren, John W. Eikelboom, Agneta Siegbahn and Steen Husted. Their work appears in journals such as Journal of the American College of Cardiology, European Heart Journal, American Heart Journal, Circulation and Journal of the American Heart Association.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.